Prospect Financial Services’s Acurx Pharmaceuticals ACXP Stock Holding History

Prospect Financial Services’s Portfolio ACXP Stock Details ACXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51.1K	Sell	13,785 -6,048	-30%	-$17.2K	0.03%	104
2025 Q4	$49.4K	Sell	19,833 -50	-0.3%	-$240	0.03%	104
2025 Q3	$85.3K	Buy	19,883 +5,044	+34%	+$30.4K	0.05%	104
2025 Q2	$152K	Sell	14,839 -3,490	-19%	-$28.1K	0.09%	100
2025 Q1	$143K	Buy	18,329 +1,875	+11%	+$25.3K	0.08%	108
2024 Q4	$268K	Buy	16,454 +1,700	+12%	+$51.2K	0.15%	92
2024 Q3	$561K	Buy	14,754 +849	+6%	+$35.9K	0.35%	47
2024 Q2	$626K	Buy	13,905 +262	+2%	+$11.5K	0.48%	40
2024 Q1	$668K	Buy	13,643 +885	+7%	+$57.5K	0.55%	39
2023 Q4	$977K	Buy	+12,758	New	+$963K	0.99%	24

Other funds holding ACXP

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.33B AUM 24% 1-Year Est. Return

Prospect Financial Services's ACXP Position: Q1 2026 in Review

Prospect Financial Services reduced its Acurx Pharmaceuticals (ACXP) stake by 30% in Q1 2026, selling an estimated $17.2K and leaving 13,785 shares worth $51.1K. The position accounts for 0.03% of the portfolio, ranked #104.

Prospect Financial Services first reported a position in ACXP in Q4 2023 and has held it in 10 quarters since. The position peaked at $977K in Q4 2023. 21 funds tracked by Wall St. Rank hold ACXP as of Q1 2026.

Prospect Financial Services held 13,785 shares of Acurx Pharmaceuticals worth $51.1K as of Q1 2026.
Prospect Financial Services sold 6,048 Acurx Pharmaceuticals shares in Q1 2026, an estimated $17.2K.
Acurx Pharmaceuticals made up 0.03% of Prospect Financial Services's portfolio in Q1 2026, its #104 holding.
Prospect Financial Services first reported a position in Acurx Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Prospect Financial Services's Acurx Pharmaceuticals position peaked at $977K in Q4 2023.
21 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2026.

Based on Prospect Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.